- Abstract Number: 045
Patient Reported Outcomes in Pediatric Vasculitis
- Abstract Number: 025
Patient- and Center-level Risk Factors for Research Lost to Follow-up Using the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry
- Abstract Number: 134
Patient-Provider Communication in Pediatric Rheumatology
- Abstract Number: 026
Performance of the UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract 2.0 Instrument in a Juvenile Systemic Sclerosis Cohort
- Abstract Number: 078
Periodic Fever Syndrome and Myelodysplastic Syndrome: Possible Connections Between Two Disorders
- Abstract Number: 017
Potential Uveitic Biomarkers in Tears of Children with Juvenile Idiopathic Arthritis: A Pilot Study
- Abstract Number: 081
Predicting Extension in Juvenile Idiopathic Arthritis
- Abstract Number: 036
Predictive Factors of Long-lasting Remission Following Anakinra Withdrawal in Patients with Systemic Juvenile Idiopathic Arthritis After Achievement of Clinical Inactive Disease
- Abstract Number: 050
Predictive Value of the 2019 EULAR/ACR SLE Criteria’s Extra-Renal Domains to Renal Response One Year After Treatment in a Pediatric Lupus Nephritis Cohort
- Abstract Number: 102
Preliminary Results from a Survey of Psychological Resilience Among JIA Patients
- Abstract Number: 104
Prevalence of Celiac Disease Among Children and Adolescents with Systemic Lupus Erythematosus (SLE)
- Abstract Number: 042
Prevalence of Chronic Pain in Childhood-onset Systemic Lupus Erythematosus and Juvenile Dermatomyositis
- Abstract Number: 092
Procalcitonin Levels in Patients with Juvenile Dermatomyositis Compared to Healthy Controls
- Abstract Number: 113
Proportion of Patients with a Polyphasic Disease Course in Systemic-onset Juvenile Idiopathic Arthritis May Be Higher in the Age of Cytokine Inhibitors
- Abstract Number: 094
Provider Assessment of the Temporomandibular Joint in Juvenile Idiopathic Arthritis
Pediatric Rheumatology Symposium 2023
March 29-April 1, 2023. New Orleans, LA.